HCA Price Prediction Next Week
Based on the technical analysis and news sentiment, here's the prediction for HCA Healthcare's stock price next week:
Technical Analysis:
- Current price: $318.09
- RSI (14) at 46.97 indicates neutral territory but slightly oversold
- MACD shows bearish divergence with MACD (0.11) crossing below signal line (1.36)
- Price trading below key SMAs (20-day: $324.31, 200-day: $344.69)
- Bollinger Bands (20,3) show price near lower band, suggesting potential bounce
News Impact:
- Recent insider selling: SVP & Chief Human Resources Officer sold 5,378 shares (~$1.73M)
- Mixed institutional sentiment with 490 increasing positions vs 677 reducing
- Q4 earnings beat expectations with strong same-facility admissions growth of 3.0%
- Analysts maintain "Moderate Buy" rating but downgraded from previous "Strong Buy"
Price Targets for Next Week:
- Support levels: $311.69 (Fibonacci S1), $307.19 (Fibonacci S2)
- Resistance levels: $326.28 (Fibonacci R1), $330.79 (Fibonacci R2)
Prediction: Based on technical indicators and recent news, HCA is likely to trade between $311-$326 next week. The most probable scenario is a slight bounce from current levels toward $322-324 area due to:
- Oversold conditions on shorter timeframes
- Price near lower Bollinger Band
- Strong fundamental performance despite insider selling
Trading Recommendation: HOLD current positions or initiate small long positions near $311-312 support with tight stops below $307. Take profits near $324-326 resistance zone.
HCA Similar Chart Price Prediction
The price of HCA is predicted to go up -2%, based on the high correlation periods with GAU. The similarity of these two price pattern on the periods is 94.35%.
HCA
GAU
Down: -2%Similarity: 94.35%
HCA Revenue Forecast
HCA EPS Forecast
HCA FAQs
What is bull’s view on HCA?
What is bear's view on HCA?
What is HCA revenue forecast for next quarter？
What is HCA eps forecast for next quarter？
HCA VS S&P500
Beyond administrative function efficiency, HCA's large scale gives it an opportunity to test and expand best practices throughout its network of facilities to improve service quality and efficiency.
HCA's focus on attractive geographic locations gives it a volume tailwind that should positively affect its top line.
The company's financial leverage should be easily manageable, giving HCA flexibility for U.S. healthcare policy changes or other shocks to the system that could constrain demand for the more elective, and highly profitable, parts of its business.
HCA Analyst's Forecast
Tim Rezvan
Keybanc
Buy
2025-01-07
Price Target
$420 → $370
Upside
+20.05%
KeyBanc analyst Matthew Gillmor lowered the firm's price target on HCA Healthcare to $370 from $420 and keeps an Overweight rating on the shares. The firm says that its revised price target reflects elevated policy uncertainty under the incoming Trump administration.
David Macdonald
Truist Securities
Strong Buy
2025-01-06
Price Target
$430 → $390
Upside
+31.35%
Craig Hettenbach
Morgan Stanley
Hold
2024-12-17
Price Target
$406 → $355
Upside
+15.34%
